Aflibercept is a vascular endothelial growth factor (VEGF) inhibitor developed by Regeneron and Bayer.
Aflibercept is a vascular endothelial growth factor (VEGF) inhibitor developed by Regeneron and Bayer. It is a recombinant fusion protein that binds to VEGF-A and placental growth factor(PIGFJ, blocking their interaction with VEGF receptors.
Indications:
Neovascular Age-related Macular Degeneration (nAMD).
Diabetic macular edema (DME)
STRENGTH:
4mg (0.1ml)
Download instructions
Contact us